tradingkey.logo
tradingkey.logo
Search

FDA Grants Priority Review For Winrevair To Update Label

ReutersJul 2, 2025 11:05 AM
facebooktwitterlinkedin

- Merck & Co Inc MRK.N:

  • FDA GRANTS PRIORITY REVIEW FOR WINREVAIR™ (SOTATERCEPT-CSRK) TO UPDATE LABEL BASED ON RESULTS FROM ZENITH TRIAL

  • MERCK & CO INC - FDA SETS PDUFA DATE OF OCT. 25, 2025 FOR WINREVAIR

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI